U.S. flag

An official website of the United States government

NM_000371.4(TTR):c.259G>C (p.Gly87Arg) AND Familial amyloid neuropathy

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Nov 29, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001303075.7

Allele description [Variation Report for NM_000371.4(TTR):c.259G>C (p.Gly87Arg)]

NM_000371.4(TTR):c.259G>C (p.Gly87Arg)

Gene:
TTR:transthyretin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q12.1
Genomic location:
Preferred name:
NM_000371.4(TTR):c.259G>C (p.Gly87Arg)
HGVS:
  • NC_000018.10:g.31595178G>C
  • NG_009490.1:g.8412G>C
  • NM_000371.4:c.259G>CMANE SELECT
  • NP_000362.1:p.Gly87Arg
  • LRG_416t1:c.259G>C
  • LRG_416:g.8412G>C
  • NC_000018.9:g.29175141G>C
  • NM_000371.3:c.259G>C
Protein change:
G87R
Links:
dbSNP: rs11541799
NCBI 1000 Genomes Browser:
rs11541799
Molecular consequence:
  • NM_000371.4:c.259G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Familial amyloid neuropathy
Synonyms:
Amyloidosis Transthyretin related; Amyloid polyneuropathy transthyretin related; TTR amyloid neuropathy; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007100; MedGen: C2751492; Orphanet: 85447; Orphanet: 85451; OMIM: 105210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001492309Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Nov 29, 2022)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV001571578Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals
no assertion criteria provided

(ACMG Guidelines, 2015)
Uncertain significance
(Dec 2, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese.

Mak CM, Kwong YL, Lam CW, Chan SC, Lo CM, Fan ST, Chang CM, Lau YK, U LS, Tam S.

Amyloid. 2007 Dec;14(4):293-7.

PubMed [citation]
PMID:
17968690

Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients.

Dai WC, Chan SC, Chok KS, Cheung TT, Sharr WW, Chan AC, Fung JY, Tsang SH, Fan ST, Lo CM.

Amyloid. 2012 Mar;19(1):33-6. doi: 10.3109/13506129.2012.655867. Epub 2012 Feb 10.

PubMed [citation]
PMID:
22320251
See all PubMed Citations (5)

Details of each submission

From Invitae, SCV001492309.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly87 amino acid residue in TTR. Other variant(s) that disrupt this residue have been observed in individuals with TTR-related conditions (PMID: 17968690, 22320251), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TTR protein function. ClinVar contains an entry for this variant (Variation ID: 1006084). This variant is also known as Gly67Arg. This missense change has been observed in individual(s) with familial transthyretin amyloidosis (PMID: 28802308). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 87 of the TTR protein (p.Gly87Arg).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Molecular Genetics Laboratory, BC Children's and BC Women's Hospitals, SCV001571578.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 15, 2024